Diabetes Management Innovations Explored in New Study Featuring Smart Insulin Delivery Technologies
Key TakeawaysDiabetes management technologies, including the Smart MDI System, show great potential to improve glycemic control and patient outcomes, particularly by reducing missed...
ISPOR Europe 2024 Plenaries and Speakers Announced
ISPOR, the leading professional society for Health Economics and Outcomes Research (HEOR), has announced the plenary sessions and speakers for ISPOR Europe 2024. As...
ISPOR Unveils Ambitious Strategic Plan 2030 to Transform Global Healthcare
ISPOR — The Professional Society for Health Economics and Outcomes Research, the leading professional society for Health Economics and Outcomes Research (HEOR), has announced...
SEPD Announces the 7th Health Economics Congress: Exploring Value-Based Reimbursement and the Power of Digital Health Records
The Health Economics and Policy Association (Sağlık Ekonomisi ve Politikası Derneği - SEPD) proudly announces the 7th Health Economics Congress, scheduled to take place...
Healthcare Innovation and Regulatory Certainty Highlighted by Cofepris at Regional Forum in Panama
Alejandro Svarch Pérez, head of the Federal Commission for the Protection against Sanitary Risks (Cofepris), underscored the critical need for regulatory certainty, transparency, and...
ECONiX Research Publishes Health Insurance Analysis of Turkish Public Health for 2023
ECONiX has released a detailed report titled "Assessment Report on Turkish Public Health Insurance Expenditures 2023," which provides an in-depth analysis of Turkiye's public...
BIOSECURE Act Could Impact US Biopharmaceutical Drugs with Half in Clinical Trials
The BIOSECURE Act could affect over 120 US biopharmaceutical drugs partnered with Chinese companies named in the bill as “companies of concern.” Of these,...
Liver Disease Focus: GSK and Ochre Bio Launch $37.5 Million AI Partnership
GlaxoSmithKline (GSK) has entered into a $37.5 million partnership with Ochre Bio to leverage artificial intelligence (AI) and advanced biological platforms to pinpoint the...
Osteogenesis Imperfecta Treatment Shows Promise: Setrusumab Reduces Fracture Rates
Ultragenyx Pharmaceutical Inc. and Mereo BioPharma Group plc today announced promising 14-month results for osteogenesis imperfecta (OI) from the Phase 2 portion of the...
Glycogen Storage Disease: Ultragenyx Announces Positive Phase 3 Results for DTX401 Gene Therapy
Ultragenyx Pharmaceutical Inc. announced positive topline results from the Phase 3 GlucoGene study (NCT05139316) evaluating DTX401, an investigational gene therapy for patients aged eight...
Ultragenyx with Sanfilippo Syndrome Treatment Secures FDA Green Light for Accelerated Approval of Gene Therapy
Ultragenyx Pharmaceutical has successfully convinced the U.S. Food and Drug Administration (FDA) to recognize a biomarker as a surrogate endpoint, allowing the company to...
Pharmaceutical Industry Calls for Political Action to Boost UK Health and Economic Growth
The Association of the British Pharmaceutical Industry (ABPI) has issued a challenge to all political parties to outline detailed plans for unlocking the potential...
Junshi Biosciences’ Hepatocellular Carcinoma Treatments Phase 3 Study Yields Positive Results
Shanghai Junshi Biosciences Co., a leading biopharmaceutical company focused on innovative therapies, has announced that its phase III clinical study (the “HEPATORCH study,” NCT04723004)...
Market Access Today Partners with World Evidence, Access and Pricing Congress 2024: A Post-Event Report
The 15th edition of the World Evidence, Access and Pricing Congress, Europe's premier Market Access and Pricing event, concluded with resounding success at the...
ICTTM Partners with Market Access Today to Boost Economic Activity and Regulatory Compliance in Biotech and Pharma
The International Centre for Trade Transparency and Monitoring (ICTTM) is excited to announce a groundbreaking strategic partnership with Market Access Today (MAT), a rapidly...
